The iliac stent market size has grown strongly in recent years. It will grow from $1.09 billion in 2025 to $1.17 billion in 2026 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to rising prevalence of peripheral artery disease, growing aging population, increased adoption of endovascular procedures, expansion of hospital-based vascular care, improved diagnosis of iliac artery lesions.
The iliac stent market size is expected to see strong growth in the next few years. It will grow to $1.5 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to growing demand for minimally invasive treatments, increasing incidence of lifestyle-related vascular disorders, expanding access to interventional cardiology services, rising healthcare expenditure in emerging economies, increasing focus on early vascular intervention. Major trends in the forecast period include rising adoption of minimally invasive peripheral interventions, increasing preference for self-expandable iliac stents, growing use of drug-eluting and covered stents in complex lesions, shift toward outpatient and day-care endovascular procedures, expansion of iliac stent usage in severe and calcified lesions.
The increasing incidence of peripheral artery diseases is anticipated to drive the expansion of the iliac stent market in the foreseeable future. Peripheral artery disease (PAD) is a vascular condition characterized by the narrowing or blockage of arteries outside the heart and brain, often attributed to factors such as smoking, an aging population, hypertension, and diabetes. Iliac stenting emerges as a valuable treatment modality for PAD patients, offering enhanced blood flow, relief from symptoms, and mitigation of complications, all while being minimally invasive and boasting a high success rate. For instance, as per data from the Society for Cardiovascular Angiography and Interventions in July 2023, PAD affects 8-10 million Americans annually, with projections estimating 19 million Americans to be affected by PAD by 2050. Hence, the escalating prevalence of peripheral artery diseases serves as a driving force for the iliac stent market.
Key players in the iliac stent market are dedicated to innovating products such as iCast to elevate patient outcomes and diminish the likelihood of complications. The iCast-covered stent system signifies a novel approach to addressing iliac artery occlusive disease, offering superior performance and a reduced risk of complications compared to conventional bare-metal stents. For instance, in October 2023, Getinge announced the US commercial availability of the iCast-covered stent system, FDA-approved for treating iliac arterial occlusive disease. This development underscores Getinge's commitment to furnishing US clinicians and hospital systems with top-tier products and support for managing this critical condition effectively.
In February 2023, Abbott Laboratories finalized the acquisition of Cardiovascular Systems Inc. (CSI) for an undisclosed sum. This strategic move by Abbott Laboratories aims to enrich its vascular device portfolio by integrating CSI's innovative atherectomy system. Cardiovascular Systems Inc. is renowned for its contributions in the realm of medical technology, particularly in manufacturing iliac stents.
Major companies operating in the iliac stent market are Cardinal Health Inc., Abbott Laboratories, Medtronic Plc, Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, W. L. Gore & Associates Inc, C. R. Bard Inc., Getinge AB, Cook Medical LLC, Biotronik SE & Co. KG, MicroPort Scientific Corporation, Cordis Corporation, Endologix Inc., LeMaitre Vascular Inc., Alvimedica, Clearstream Technologies Ltd., Jotec GmbH, Translumina GmbH, Vascular Concepts Limited, Lombard Medical Technologies, Acandis GmbH, Gore Medical, Medizintechnik GmbH.
North America was the largest region in the iliac stent market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the iliac stent market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the iliac stent market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have created cost pressures and supply chain challenges in the iliac stent market by increasing prices of imported raw materials, metallic alloys, and precision medical components used in stent manufacturing. These impacts have affected production timelines and pricing strategies, particularly for balloon-expandable and drug-eluting stents, with Asia-pacific and north america experiencing the most disruption due to reliance on cross-border medical device trade. Hospitals and outpatient facilities have faced higher procurement costs, influencing purchasing decisions and reimbursement dynamics. However, tariffs have also encouraged local manufacturing, regional sourcing, and domestic capacity expansion, supporting supply chain resilience and long-term market stability.
The iliac stent market research report is one of a series of new reports that provides iliac stent market statistics, including iliac stent industry global market size, regional shares, competitors with a iliac stent market share, detailed iliac stent market segments, market trends and opportunities, and any further data you may need to thrive in the iliac stent industry. This iliac stent market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Iliac stents are specialized medical devices crafted to address atherosclerosis in the iliac arteries, situated in the pelvic region. These stents are deployed through minimally invasive procedures such as angioplasty to widen and provide support to narrowed or obstructed arteries.
The primary types of iliac stents include self-expandable stents, balloon-expandable stents, and others. Self-expandable stents are medical instruments utilized for treating narrowed or obstructed blood vessels in various parts of the body, including the coronary arteries, peripheral arteries, and other tubular structures. They are employed in the treatment of various artery lesions such as common iliac artery lesions, severe calcified lesions, and complete obstructive lesions. These stents are utilized by a range of end-users including hospitals, outpatient facilities, and others.
The iliac stents market consists of sales of coronary stents, biliary stents, and ureteral stents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The iliac stent market size is expected to see strong growth in the next few years. It will grow to $1.5 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to growing demand for minimally invasive treatments, increasing incidence of lifestyle-related vascular disorders, expanding access to interventional cardiology services, rising healthcare expenditure in emerging economies, increasing focus on early vascular intervention. Major trends in the forecast period include rising adoption of minimally invasive peripheral interventions, increasing preference for self-expandable iliac stents, growing use of drug-eluting and covered stents in complex lesions, shift toward outpatient and day-care endovascular procedures, expansion of iliac stent usage in severe and calcified lesions.
The increasing incidence of peripheral artery diseases is anticipated to drive the expansion of the iliac stent market in the foreseeable future. Peripheral artery disease (PAD) is a vascular condition characterized by the narrowing or blockage of arteries outside the heart and brain, often attributed to factors such as smoking, an aging population, hypertension, and diabetes. Iliac stenting emerges as a valuable treatment modality for PAD patients, offering enhanced blood flow, relief from symptoms, and mitigation of complications, all while being minimally invasive and boasting a high success rate. For instance, as per data from the Society for Cardiovascular Angiography and Interventions in July 2023, PAD affects 8-10 million Americans annually, with projections estimating 19 million Americans to be affected by PAD by 2050. Hence, the escalating prevalence of peripheral artery diseases serves as a driving force for the iliac stent market.
Key players in the iliac stent market are dedicated to innovating products such as iCast to elevate patient outcomes and diminish the likelihood of complications. The iCast-covered stent system signifies a novel approach to addressing iliac artery occlusive disease, offering superior performance and a reduced risk of complications compared to conventional bare-metal stents. For instance, in October 2023, Getinge announced the US commercial availability of the iCast-covered stent system, FDA-approved for treating iliac arterial occlusive disease. This development underscores Getinge's commitment to furnishing US clinicians and hospital systems with top-tier products and support for managing this critical condition effectively.
In February 2023, Abbott Laboratories finalized the acquisition of Cardiovascular Systems Inc. (CSI) for an undisclosed sum. This strategic move by Abbott Laboratories aims to enrich its vascular device portfolio by integrating CSI's innovative atherectomy system. Cardiovascular Systems Inc. is renowned for its contributions in the realm of medical technology, particularly in manufacturing iliac stents.
Major companies operating in the iliac stent market are Cardinal Health Inc., Abbott Laboratories, Medtronic Plc, Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, W. L. Gore & Associates Inc, C. R. Bard Inc., Getinge AB, Cook Medical LLC, Biotronik SE & Co. KG, MicroPort Scientific Corporation, Cordis Corporation, Endologix Inc., LeMaitre Vascular Inc., Alvimedica, Clearstream Technologies Ltd., Jotec GmbH, Translumina GmbH, Vascular Concepts Limited, Lombard Medical Technologies, Acandis GmbH, Gore Medical, Medizintechnik GmbH.
North America was the largest region in the iliac stent market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the iliac stent market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the iliac stent market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have created cost pressures and supply chain challenges in the iliac stent market by increasing prices of imported raw materials, metallic alloys, and precision medical components used in stent manufacturing. These impacts have affected production timelines and pricing strategies, particularly for balloon-expandable and drug-eluting stents, with Asia-pacific and north america experiencing the most disruption due to reliance on cross-border medical device trade. Hospitals and outpatient facilities have faced higher procurement costs, influencing purchasing decisions and reimbursement dynamics. However, tariffs have also encouraged local manufacturing, regional sourcing, and domestic capacity expansion, supporting supply chain resilience and long-term market stability.
The iliac stent market research report is one of a series of new reports that provides iliac stent market statistics, including iliac stent industry global market size, regional shares, competitors with a iliac stent market share, detailed iliac stent market segments, market trends and opportunities, and any further data you may need to thrive in the iliac stent industry. This iliac stent market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Iliac stents are specialized medical devices crafted to address atherosclerosis in the iliac arteries, situated in the pelvic region. These stents are deployed through minimally invasive procedures such as angioplasty to widen and provide support to narrowed or obstructed arteries.
The primary types of iliac stents include self-expandable stents, balloon-expandable stents, and others. Self-expandable stents are medical instruments utilized for treating narrowed or obstructed blood vessels in various parts of the body, including the coronary arteries, peripheral arteries, and other tubular structures. They are employed in the treatment of various artery lesions such as common iliac artery lesions, severe calcified lesions, and complete obstructive lesions. These stents are utilized by a range of end-users including hospitals, outpatient facilities, and others.
The iliac stents market consists of sales of coronary stents, biliary stents, and ureteral stents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Iliac Stent Market Characteristics
3. Iliac Stent Market Supply Chain Analysis
4. Global Iliac Stent Market Trends and Strategies
5. Iliac Stent Market Analysis of End Use Industries
7. Global Iliac Stent Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Iliac Stent Total Addressable Market (TAM) Analysis for the Market
9. Iliac Stent Market Segmentation
10. Iliac Stent Market Regional and Country Analysis
11. Asia-Pacific Iliac Stent Market
12. China Iliac Stent Market
13. India Iliac Stent Market
14. Japan Iliac Stent Market
15. Australia Iliac Stent Market
16. Indonesia Iliac Stent Market
17. South Korea Iliac Stent Market
18. Taiwan Iliac Stent Market
19. South East Asia Iliac Stent Market
20. Western Europe Iliac Stent Market
21. UK Iliac Stent Market
22. Germany Iliac Stent Market
23. France Iliac Stent Market
24. Italy Iliac Stent Market
25. Spain Iliac Stent Market
26. Eastern Europe Iliac Stent Market
27. Russia Iliac Stent Market
28. North America Iliac Stent Market
29. USA Iliac Stent Market
30. Canada Iliac Stent Market
31. South America Iliac Stent Market
32. Brazil Iliac Stent Market
33. Middle East Iliac Stent Market
34. Africa Iliac Stent Market
36. Iliac Stent Market Competitive Landscape and Company Profiles
37. Iliac Stent Market Other Major and Innovative Companies
40. Iliac Stent Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Iliac Stent Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses iliac stent market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for iliac stent? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The iliac stent market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Self-Expandable Stents; Balloon-Expandable Stents; Other Types2) By Artery Lesions: Common Iliac Artery Lesions; Severe Calcified Lesions
3) By End-Users: Hospitals; Outpatient Facilities; Other End-Users
Subsegments:
1) By Self-Expandable Stents: Nitinol Self-Expandable Stents; Polymer-Coated Self-Expandable Stents2) By Balloon-Expandable Stents: Bare-Metal Balloon-Expandable Stents; Drug-Eluting Balloon-Expandable Stents
3) By Other Types: Covered Stents; Hybrid Stents
Companies Mentioned: Cardinal Health Inc.; Abbott Laboratories; Medtronic Plc; Becton Dickinson and Company; Boston Scientific Corporation; B. Braun Melsungen AG; Terumo Corporation; W. L. Gore & Associates Inc; C. R. Bard Inc.; Getinge AB; Cook Medical LLC; Biotronik SE & Co. KG; MicroPort Scientific Corporation; Cordis Corporation; Endologix Inc.; LeMaitre Vascular Inc.; Alvimedica; Clearstream Technologies Ltd.; Jotec GmbH; Translumina GmbH; Vascular Concepts Limited; Lombard Medical Technologies; Acandis GmbH; Gore Medical; Medizintechnik GmbH
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Iliac Stent market report include:- Cardinal Health Inc.
- Abbott Laboratories
- Medtronic Plc
- Becton Dickinson and Company
- Boston Scientific Corporation
- B. Braun Melsungen AG
- Terumo Corporation
- W. L. Gore & Associates Inc
- C. R. Bard Inc.
- Getinge AB
- Cook Medical LLC
- Biotronik SE & Co. KG
- MicroPort Scientific Corporation
- Cordis Corporation
- Endologix Inc.
- LeMaitre Vascular Inc.
- Alvimedica
- Clearstream Technologies Ltd.
- Jotec GmbH
- Translumina GmbH
- Vascular Concepts Limited
- Lombard Medical Technologies
- Acandis GmbH
- Gore Medical
- Medizintechnik GmbH
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.17 Billion |
| Forecasted Market Value ( USD | $ 1.5 Billion |
| Compound Annual Growth Rate | 6.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 26 |
